NOVEL METABOTROPIC GLUTAMATE-RECEPTOR AGONIST - (2S,1'S,2'R,3'R)-2-(2-CARBOXY-3-METHOXYMETHYLCYCLOPROPYL)GLYCINE (CIS-MCG-I)

被引:31
|
作者
ISHIDA, M
SAITOH, T
NAKAMURA, Y
KATAOKA, K
SHINOZAKI, H
机构
[1] TOKYO METROPOLITAN INST MED SCI,DEPT PHARMACOL,BUNKYO KU,TOKYO 113,JAPAN
[2] EHIME UNIV,SCH MED,DEPT PHYSIOL,SHIGENOBU,EHIME 79102,JAPAN
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1994年 / 268卷 / 02期
关键词
METABOTROPIC GLUTAMATE RECEPTOR; SPINAL CORD; ISOLATED; CAMP; PHOSPHOINOSITIDE HYDROLYSIS; L-CCG-I((2S; I'S; 2'S)-CCG); CORTICAL CELL CULTURE; ACPD ((1S,3R)-1-AMINOCYCLOPENTANE-1,3-DICARBOXYLATE);
D O I
10.1016/0922-4106(94)90198-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A novel agonist for metabotropic glutamate receptors, (2S,1'S,2'R,3'R)-2-(2-carboxy-3-methoxymethylcyclop ropyl)glycine (cis-MCG-I), effectively inhibited monosynaptic excitation in newborn rat spinal cords with EC(50) of 3 mu M without causing any depolarization. Furthermore, cis-MCG-I inhibited the forskolin-stimulated cyclic AMP formation in rat cultured cortical cells with IC50 of 1.5 mu M. cis-MCG-I neither stimulated the phosphoinositide hydrolysis nor activated ionotropic glutamate receptors even in high concentrations. However, after a brief exposure of spinal cords to quisqualate, it caused depolarization in a dose-dependent manner. This compound would provide useful information for elucidating physiological functions of metabotropic glutamate receptors.
引用
收藏
页码:267 / 270
页数:4
相关论文
共 29 条
  • [21] The Metabotropic Glutamate 2/3 Receptor Agonist LY379268 Blocked Nicotine-Induced Increases in Nucleus Accumbens Shell Dopamine only in the Presence of a Nicotine-Associated Context in Rats
    D'Souza, Manoranjan S.
    Liechti, Matthias E.
    Ramirez-Nino, Ana M.
    Kuczenski, Ronald
    Markou, Athina
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (10) : 2111 - 2124
  • [22] The Metabotropic Glutamate 2/3 Receptor Agonist LY379268 Blocked Nicotine-Induced Increases in Nucleus Accumbens Shell Dopamine only in the Presence of a Nicotine-Associated Context in Rats
    Manoranjan S D'Souza
    Matthias E Liechti
    Ana M Ramirez-Niño
    Ronald Kuczenski
    Athina Markou
    Neuropsychopharmacology, 2011, 36 : 2111 - 2124
  • [23] A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model
    Puttfarcken, Pamela S.
    Han, Ping
    Joshi, Shailen K.
    Neelands, Torben R.
    Gauvin, Donna M.
    Baker, Scott J.
    Lewis, La Geisha R.
    Bianchi, Bruce R.
    Mikusa, Joseph P.
    Koenig, John R.
    Perner, Richard J.
    Kort, Michael E.
    Honore, Prisca
    Faltynek, Connie R.
    Kym, Philip R.
    Reilly, Regina M.
    PAIN, 2010, 150 (02) : 319 - 326
  • [24] Key Amino Acid Residues Involved in Multi-Point Binding Interactions between Brazzein, a Sweet Protein, and the T1R2-T1R3 Human Sweet Receptor
    Assadi-Porter, Fariba M.
    Maillet, Emeline L.
    Radek, James T.
    Quijada, Jeniffer
    Markley, John L.
    Max, Marianna
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 398 (04) : 584 - 599
  • [25] Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG
    Bäckström, P
    Hyytiä, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 528 (1-3) : 110 - 118
  • [26] MODELING ANALYSIS OF INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR (IP3R)-MEDIATED CA2+MOBILIZATION FROM INTRACELLULAR CA2+STORES IN PANCREATIC BETA CELLS
    Takeda, Y.
    Shimayoshi, T.
    Holz, G.
    Noma, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S122 - S122
  • [27] Functional characterization of the heterodimeric sweet taste receptor T1R2 and T1R3 from a New World monkey species (squirrel monkey) and its response to sweet-tasting proteins
    Liu, Bo
    Ha, Matthew
    Meng, Xuan-Yu
    Khaleduzzaman, Mohammed
    Zhang, Zhe
    Li, Xia
    Cui, Meng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 427 (02) : 431 - 437
  • [28] Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)
    Chang, Steven D.
    Brieaddy, Lawrence E.
    Harvey, Joseph D.
    Lewin, Anita H.
    Mascarella, S. Wayne
    Seltzman, Herbert H.
    Reddy, P. Anantha
    Decker, Ann M.
    McElhinny, Charles J., Jr.
    Zhong, Desong
    Peterson, Elisha E.
    Navarro, Hernan A.
    Bruchas, Michael R.
    Carroll, F. Ivy
    ACS CHEMICAL NEUROSCIENCE, 2015, 6 (12): : 1956 - 1964
  • [29] Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: Design, synthesis, and structure-activity relationships
    Hayashi, Shigeo
    Nakata, Eriko
    Morita, Asato
    Mizuno, Kunihiko
    Yamamura, Kenzo
    Kato, Aki
    Ohashi, Katsuyo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (21) : 7675 - 7699